Pay in 4 interest-free payments of $5.14 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide, a triple-agonist (GLP-1, GIP and glucagon), is in late-stage trials and has produced even more weight loss in early data up to 24% at 48 weeks in phase 2
Vitamin C: An essential nutrient known for its antioxidant properties
In other words, appetite suppression is temporary
It may carry some protection against skin cancer
Clinical trials are currently observing the following potential benefits beyond weight reduction: Improved Metabolic Health: Retatrutide can help improve insulin sensitivity and support better blood sugar regulation, which is vital for individuals with prediabetes or type 2 diabetes
& Reece, E
US$ 25.95
US$ 29.03
US$ 26.87
